Bitcoin Surges to All-Time High After Trump Reelection The Buzz Around Bitcoin Bitcoin has experienced a notable surge in price, reaching an all-time high of $75,358 following the announcement that former US President Donald Trump has been reelected, becoming the 47th President of the United States. So far, the asset’s value has seen a nearly…
President Joe Biden may have called supporters of former President Donald Trump “garbage” last week, sparking a unique protest at the polls in Perry Hall, MD. Baltimore County Republican Jeff Insley showed up to vote for Trump wearing a trash bag, embodying the President’s derogatory term. Insley’s unconventional protest sparked a conversation about the current…
The Impact of the 2024 Election on Bond Markets A Surprising Turn of Events The 10-year Treasury yield (^TNX) edges closer to that 4.5% benchmark following Donald Trump’s win over Vice President Kamala Harris in the 2024 election. While equity markets have taken off this morning, the bond market’s potential is still uncertain as more…
To EV or not to EV: Toyota’s Dilemma A Bumpy Ride for Toyota in Q2 Toyota Motor Corporation’s fiscal Q2 was met with some obstacles, as production halts and macroeconomic weakness, particularly in the European market, took a toll on the company’s performance. Despite these challenges, Toyota’s outlook remains stable, with a steady performance underlying…
Exciting News from INOVIO: DNA Medicines Making Waves in the Medical Community PLYMOUTH MEETING, Pa. , Nov. 6, 2024 /PRNewswire/ — INOVIO (NASDAQ:INO) INOVIO (NASDAQ:INO), a pioneering biotechnology company, is making headlines once again with its revolutionary approach to treating HPV-related diseases, cancer, and infectious diseases through DNA medicines. The company has just announced its…
Genmab Interim Report Highlights Exciting Developments in Cancer Therapy Key Points from the Interim Report: TEPKINLY Approval: The European Commission has granted conditional marketing authorization for TEPKINLY as a monotherapy for the treatment of adult patients with relapsed or refractory follicular lymphoma. This is a significant milestone in the fight against cancer. Genmab’s Responsibility: Genmab…
The Schwab U.S. Large-Cap Growth ETF: A Smart Investment Choice Investing in the Future: The Rise of AI and Tech Giants The Schwab U.S. Large-Cap Growth ETF presents a compelling opportunity for investors looking to capitalize on the strength of the largest U.S. corporations with solid fundamentals. At the forefront of this investment is the…
Welcome to the Future of Eye Therapy with Clearside Biomedical Breaking News: Fireside Chat at Stifel 2024 Healthcare Conference ALPHARETTA, Ga., Nov. 06, 2024 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today George Lasezkay,…
